De-risk

Your Investment

OPTIMISE

Drug Discovery

IMPROVE

Patient Outcomes

SAVE

Time & Money

 

We are ILLUSTRATUM, a British biotechnology company who are commercialising DARC Technology, developed by Professor M Francesca Cordeiro through Wellcome Trust funding. 

Francesca Cordeiro is a Professor at UCL Institute of Ophthalmology and Imperial College London and is Director of the clinical trials unit at The Western Eye Hospital. 

DARC Technology combines an innovative patented biomarker and a state of the art AI algorithm, enabling early-stage glaucoma and AMD to be identified years ahead of current technology.

DARC as a consequence could enable cost effective assessment of potential drug candidates.

DARC can identify patients who will demonstrate faster progression of disease based on conventional end points.